NetworkNewsBreaks

TuesdayMar 03, 2020 11:49 am

NetworkNewsBreaks – Zogenix Inc. (NASDAQ: ZGNX) Featured in Mizuho Securities Research Report

Zogenix Inc. (NASDAQ: ZGNX) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “Earlier this morning, Zogenix announced that the FDA has extended the PDUFA date for FINTEPLA by 3 months, to June 25, 2020, to allow more time to review additional data submitted by Zogenix. We spoke with management - they noted that the additional data requests were related to efficacy only, not safety. And this data was already in-hand, i.e., no requirement for additional clinical trials. In a number of precedent cases of PDUFA date extensions highlighted below, all drugs…

Continue Reading

TuesdayMar 03, 2020 11:31 am

NetworkNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Announces Launch of “Nutrition for the Ears” Dietary Hearing and Tinnitus Supplements on Amazon Prime

InnerScope Hearing Technologies (OTC: INND) today announced that its complete line of Doctor-Formulated "Nutrition for the Ears" Dietary Hearing and Tinnitus Supplements can be purchased on Amazon.com and Amazon Prime Subscribers can receive free and fast shipping. “We are excited to now offer to Amazon's reported 150 million Prime Subscribers our complete line of Doctor-Formulated ‘Nutrition for the Ears’ Dietary Hearing and Tinnitus Supplements,” InnerScope Hearing Technologies CEO Matthew Moore said in the news release. “We are equally excited about the future prospect of having InnerScope's Self-Fitting FDA-Registered Hearing Aid also sold on Amazon's sales platform. Using Amazon.com, the world's…

Continue Reading

TuesdayMar 03, 2020 11:15 am

NetworkNewsBreaks – Sigma Labs, Inc. (NASDAQ: SGLB) Awarded Contract to Implement PrintRite3D Real-Time Melt Pool Analytics Technology at Northwestern University

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the commercial 3D printing industry, today announced that it has been awarded a contract to implement its PrintRite3D Real-Time Melt Pool Analytics technology at Northwestern University. According to the update, Sigma Labs will integrate the PrintRite3D system to a DMG Mori LASERTEC12 Selective Laser Melting machine in collaboration with two university research centers at Northwestern University - Northwestern Initiative on Manufacturing Science and Innovation (“NIMSI”) and Center for Hierarchical Materials Design (“CHiMaD”). NIMSI researchers have developed computer-integrated systems for innovative subtractive, deformation-based and additive manufacturing processes. Sigma Labs…

Continue Reading

TuesdayMar 03, 2020 11:00 am

NetworkNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) Reports Revenues of $5.5M for Quarter Ended December 31, 2019

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) this morning reported financial results for the second quarter ended December 31, 2019, including $5,514,502 in revenues for the quarter, representing a substantial increase from $1,410,135 during the same period of the previous year. Per the update, revenues were projected to be down as a result of the sudden drop in vape sales and the close of the company’s Robson store to move to its newly renovated, licensed, 2,800-square-foot facility at Robson and Granville. To view the full press release, visit http://nnw.fm/Pb7W9 About Wildflower Brands Wildflower Brands is a Vancouver-based pioneer in the cannabis…

Continue Reading

TuesdayMar 03, 2020 10:49 am

NetworkNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Announces 91% Sequential Growth to $1.35 Million and Significant Financial Improvements

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. and California cannabis marketplaces, today announced robust growth and significant financial improvements for the most recently completed financial period ending Dec. 31, 2019. Cannabis Strategic Ventures reported revenue of $1.35 million for the quarter ending Dec. 31, representing approximately 91% sequential growth compared to the previous quarter. According to the update, gross margins grew meaningfully while operating efficiencies significantly improved. “We’re excited to see consistent revenue growth,” Simon Yu, CEO of the Company, said in the news release.  “In this highly regulated environment, it takes time to scale production. …

Continue Reading

TuesdayMar 03, 2020 10:15 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Present at the Third Annual LD Micro Virtual Conference

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, today announced that it will present at the third annual LD Micro Virtual Conference at 1:40 p.m. EST on Wednesday, March 4. Genprex’s Chairman and Chief Executive Officer, Rodney Varner, will lead the company’s presentation and answer questions from investors. “We are delighted to be hosting our third virtual event in order to showcase some of the truly unique names in micro-cap,” LD Micro President Chris Lahiji said in the news release. “There are many people and companies who are unable to…

Continue Reading

TuesdayMar 03, 2020 10:09 am

NetworkNewsBreaks – Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) to Present White Paper on Groundbreaking Technology at Car Training Institute Symposium

Exro Technologies (CSE: XRO) (OTCQB: EXROF) this morning announced that the company has been invited to present a white paper titled, ‘The Coil Switching Inverter - A Step Change in Powertrain Design’, to the Car Training Institute (“CTI”), the world's leading summit on advances in automotive transmission, hybrid and electric drive technologies. Exro Chief Technology Officer Ari Berger will be presenting a thorough outline of the company's pioneering technology, which significantly improves the performance and output of electric motors and powertrains, at the CTI USA Symposium, which will be held in Novi, Michigan from May 11 to 14, 2020. “We…

Continue Reading

TuesdayMar 03, 2020 9:44 am

NetworkNewsBreaks – Nightfood Holdings Inc. (NGTF), the Official Ice Cream of the APA, to Exhibit at the American College of Obstetricians and Gynecologists 2020 Conference

Nightfood Holdings (OTCQB: NGTF), the better-for-you ice cream recently recommended as the Official Ice Cream of the American Pregnancy Association (“APA”), today announced that it will present to thousands of OBGYNs at the upcoming annual conference of the American College of Obstetricians and Gynecologists (“ACOG”). This year’s conference is slated to be held in Seattle on April 24 - 27, 2020, and attract over 5,000 attendees, including several thousand physicians. According to the ACOG website, the event brings together influential and notable professionals within the specialty to obtain new information and learn the newest techniques in order to better serve…

Continue Reading

TuesdayMar 03, 2020 9:25 am

NetworkNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Management to Provide Presentation at 32nd Annual ROTH Conference

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, this morning announced that the company’s Chief Financial Officer Eli Yoresh and Vice President of Business Development Doron Cohadier will present at the 32nd Annual ROTH Conference, which is taking place from March 15-17, 2020 at The Ritz Carlton, Laguna Niguel, CA. Foresight’s presentation is scheduled to take place on Monday, March 16, 2020 at 11:00 AM PST. Additionally, Doron Cohadier will participate in a panel titled, “Connected Automobile” at 12 PM PST on March 16. Management will also be available throughout March 16 and 17 for…

Continue Reading

MondayMar 02, 2020 2:01 pm

NetworkNewsBreaks – Altimmune Inc. (NASDAQ: ALT) Featured in ROTH Equity Research Report

Altimmune Inc. (NASDAQ: ALT) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We resume coverage of Altimmune, Inc. (ALT) with a Buy rating and a $13/share price target. In this report, we detail how, given the bearish NASH sentiment ahead of Ph2b semaglutide (sema) data in May, ALT represents a buying opportunity with its dual GLP-1:glucagon agonist, ALT-801, positioned to benefit from validation of weight loss as a NASH MOA but differentiated to push the bar higher on weight loss with potentially less GI side effects.” To request access to the…

Continue Reading